Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

The efficacy and safety of a combination of tinidazole and thioconazole in the treatment of vaginal infections

Торшин И. Y. У., Аполихина И. А., Баранов И. И., Тапилскайа Н. И., Савичева А. М., Громова О. А.
Акушерство и гинекология
Т. 2020, Вып. 4, С. 214-222
Опубликовано: 2020
Тип ресурса: Статья

DOI:10.18565/aig.2020.4.214-222

Аннотация:
The paper gives the results from a meta-analysis of clinical trials using Gainomax (its standard dose is thioconazole 100 mg, tinidazole 150 mg as a suppository or cream) for the therapy of vulvovaginal candidiasis (VVC), bacterial vaginosis (BV), and trichomaniasis (TM). The meta-analysis included 4 clinical trials (covering 209 patients). The patients’ mean age was 35±7 years (95[%] CI, 18-52); all the patients used Gainomax suppositories/cream at the standard dose for 7 days or double dose for 3 days. Gainomax therapy substantially increased the chances of clinical cure of BV (by 20 times; OR 20.4; 95[%] CI 9.5-43.6), microbiological cure of BV (by 16 times; OR 15.5; 95[%] CI 7.6-31.5), cures of VVC (by 21 times; OR 21.0; 95[%] CI 8.8-50.2) and TM (by 29 times; OR 28.8; 95[%] CI 7.4-111.8). Analyzing individual clinical symptoms revealed associations between drug use and a statistically significant reduction in pathological vaginal discharge (by 25 times; OR 0.04; 95[%] CI 0.02-0.08), inflammat
Ключевые слова:
Bacterial vaginosis (BV); Evidence-based medicine; Gainomax; Meta-analysis; Suppositories; Trichomoniasis (TM); Vulvovaginal candidiasis (VVC)
gainomax; tinidazole; tioconazole; Article; clinical trial (topic); combination drug therapy; cream; drug efficacy; drug safety; drug use; female; human; inflammation; meta analysis; suppository; unspecified side effect; vagina candidiasis; vagina discharge (disease); vaginal trichomoniasis; vaginitis
Язык текста: Русский
ISSN: 0300-9092
Торшин И. Y. У.
Аполихина И. А. Инна Анатольевна 1963-
Баранов И. И.
Тапилскайа Н. И.
Савичева А. М.
Громова О. А.
Torshin I. Y. U.
Apolikhina I. A. Inna Anatolyevna 1963-
Baranov I. I.
Tapilskaya N. I.
Savicheva A. M.
Gromova O. A.
The efficacy and safety of a combination of tinidazole and thioconazole in the treatment of vaginal infections
Текст визуальный непосредственный
Акушерство и гинекология
Бионика Медиа
Т. 2020, Вып. 4 С. 214-222
2020
Статья
Bacterial vaginosis (BV) Evidence-based medicine Gainomax Meta-analysis Suppositories Trichomoniasis (TM) Vulvovaginal candidiasis (VVC)
gainomax tinidazole tioconazole Article clinical trial (topic) combination drug therapy cream drug efficacy drug safety drug use female human inflammation meta analysis suppository unspecified side effect vagina candidiasis vagina discharge (disease) vaginal trichomoniasis vaginitis
The paper gives the results from a meta-analysis of clinical trials using Gainomax (its standard dose is thioconazole 100 mg, tinidazole 150 mg as a suppository or cream) for the therapy of vulvovaginal candidiasis (VVC), bacterial vaginosis (BV), and trichomaniasis (TM). The meta-analysis included 4 clinical trials (covering 209 patients). The patients’ mean age was 35±7 years (95[%] CI, 18-52); all the patients used Gainomax suppositories/cream at the standard dose for 7 days or double dose for 3 days. Gainomax therapy substantially increased the chances of clinical cure of BV (by 20 times; OR 20.4; 95[%] CI 9.5-43.6), microbiological cure of BV (by 16 times; OR 15.5; 95[%] CI 7.6-31.5), cures of VVC (by 21 times; OR 21.0; 95[%] CI 8.8-50.2) and TM (by 29 times; OR 28.8; 95[%] CI 7.4-111.8). Analyzing individual clinical symptoms revealed associations between drug use and a statistically significant reduction in pathological vaginal discharge (by 25 times; OR 0.04; 95[%] CI 0.02-0.08), inflammat